NO971625L - Nye peptider med immunomodulatoriske effekter - Google Patents

Nye peptider med immunomodulatoriske effekter

Info

Publication number
NO971625L
NO971625L NO971625A NO971625A NO971625L NO 971625 L NO971625 L NO 971625L NO 971625 A NO971625 A NO 971625A NO 971625 A NO971625 A NO 971625A NO 971625 L NO971625 L NO 971625L
Authority
NO
Norway
Prior art keywords
novel peptides
immunomodulatory effects
peptides
preparation
novel
Prior art date
Application number
NO971625A
Other languages
English (en)
Norwegian (no)
Other versions
NO971625D0 (no
Inventor
Haakan Bergstrand
Tomas Erikson
Kostas Karabelas
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO971625D0 publication Critical patent/NO971625D0/no
Publication of NO971625L publication Critical patent/NO971625L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO971625A 1994-10-14 1997-04-09 Nye peptider med immunomodulatoriske effekter NO971625L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (2)

Publication Number Publication Date
NO971625D0 NO971625D0 (no) 1997-04-09
NO971625L true NO971625L (no) 1997-05-30

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971625A NO971625L (no) 1994-10-14 1997-04-09 Nye peptider med immunomodulatoriske effekter

Country Status (20)

Country Link
US (2) US6103697A (sk)
EP (1) EP0783519A1 (sk)
JP (1) JPH10507448A (sk)
AU (1) AU705364B2 (sk)
BR (1) BR9509345A (sk)
CA (1) CA2201479A1 (sk)
CZ (1) CZ111997A3 (sk)
EE (1) EE9700087A (sk)
FI (1) FI971499A (sk)
HU (1) HUT77118A (sk)
IL (1) IL115509A0 (sk)
IS (1) IS4459A (sk)
MX (1) MX9702666A (sk)
NO (1) NO971625L (sk)
PL (1) PL319631A1 (sk)
SE (1) SE9403526D0 (sk)
SK (1) SK46797A3 (sk)
TR (1) TR199501255A2 (sk)
WO (1) WO1996011943A1 (sk)
ZA (1) ZA958140B (sk)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
AU2417597A (en) * 1996-04-12 1997-11-07 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory ef fects
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
EP1083872A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
AP2695A (en) 2005-04-25 2013-07-16 Cadila Pharmaceuticals Ltd Vaccine adjuvants
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
AU1366088A (en) 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) * 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
EP0548200B1 (en) 1990-09-11 1999-04-14 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
KR100260342B1 (ko) 1991-10-16 2000-07-01 스타세이 엘. 첸링 더마토파고이드로 부터 유래된 알레르겐의 t세포 에피토프
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
EP0703783B1 (en) 1993-03-05 2010-05-05 Epimmune Inc. Methods of making immunogenic hla-a2.1 binding peptides
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
EE03451B1 (et) 1994-07-05 2001-06-15 Steeno Research Group A/S Immunomodulaatorid
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
CZ111997A3 (en) 1997-12-17
US6103697A (en) 2000-08-15
TR199501255A2 (tr) 1996-06-21
JPH10507448A (ja) 1998-07-21
SK46797A3 (en) 1997-09-10
ZA958140B (en) 1997-06-27
AU705364B2 (en) 1999-05-20
EE9700087A (et) 1997-10-15
HUT77118A (hu) 1998-03-02
EP0783519A1 (en) 1997-07-16
AU3713395A (en) 1996-05-06
IL115509A0 (en) 1996-05-14
IS4459A (is) 1997-04-08
NO971625D0 (no) 1997-04-09
US6228374B1 (en) 2001-05-08
SE9403526D0 (sv) 1994-10-14
WO1996011943A1 (en) 1996-04-25
FI971499A0 (fi) 1997-04-10
MX9702666A (es) 1997-06-28
BR9509345A (pt) 1997-11-25
PL319631A1 (en) 1997-08-18
CA2201479A1 (en) 1996-04-25
FI971499A (fi) 1997-06-10

Similar Documents

Publication Publication Date Title
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
ES2056214T3 (es) Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso.
ATE255589T1 (de) Kristallin form i von clarithromycin
NO955047L (no) Sekundære aminer som antidiabetiske og antifedme-midler
TR199901578T2 (xx) Klaritromisin form 0 kristali
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
NO962286L (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
SE9904505D0 (sv) Novel compounds
SE9902987D0 (sv) Novel compounds
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
NO996108L (no) 9-oksinerytromycinderivater
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
DK15589D0 (da) Kemiske forbindelser
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
BR0007589A (pt) Inibidores da proliferação de células
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
NO995431L (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse